Page 2 - Zydus Lifesciences Ltd News

Zydus Lifesciences marks China entry with approval for antidepressant drug

Indian drug cos Chinese pipelines start getting regulator nod; Glenmark got nod for nasal spray this week

Zydus Life Q2: Solid beat on bottom line, analysts mixed on growth outlook

Zydus Life Q2 results review: Foreign brokerage Nomura said Zydus Life delivered results above estimates, led by a stronger-than-expected performance in India.

Zydus PAT up 38% on strong India, US growth; board okays ₹5K cr fundraise

Zydus Lifesciences reported a 17% YoY rise in revenue to Rs 6,123 crore and a 38% jump in profit to Rs 1,258.6 crore in Q2 FY26, driven by India and US formulations performance

Stocks to Watch today, Nov 4: Bharti Airtel, Titan, Hero MotoCorp, Cipla

Stocks to Watch today, November 4, 2025: From Bharti Airtel, Hero MotoCorp, Titan Company, and Power Grid, here is a list of stocks that will be in focus today

Stocks to Watch today: Coal India, L&T, Wipro, Bharti Airtel, Ola Electric

Stocks to Watch Today, October 30, 2025: Wipro, L&T, Coal India, United Breweries, Ola Electric, ITC, Swiggy, Mankind Pharma, and Dr Reddy's Labs are among the top stocks to watch today

Stocks to Watch today, Oct 7: LTIMindtree, Bank of India, HCL Tech, OIL

Stocks to Watch today, October 7, 2025: From Bank of India, HCL Tech to Eternal, here is a list of stocks that will be in focus

Tariff uncertainties may spur rise in third-party pharma manufacturing

Analysts say Indian drugmakers may lean on CDMOs, US plants and diversification to safeguard high-value products as Trump's 100% tariff threat looms over patented drugs

Nifty Pharma down 2.5% as Trump slaps 100% import tariffs; impact decoded

Among individual counters, Sun Pharma slumped 4.87 per cent to a fresh 52-week low of ₹1,548, while Gland Pharma tumbled 4.70 per cent to ₹1,880. Biocon declined 3.68 per cent to ₹342.85.

Stocks to watch today, Sep 8: SpiceJet, TaMo, M&M, Vedanta, BHEL, HFCL

Stocks to watch today, September 8, 2025 | Aurobindo Pharma: USFDA issued 8 procedural observations after inspecting Telangana Unit-XII.